Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial.
Pautier P, Italiano A, Piperno-Neumann S, Chevreau C, Penel N, Firmin N, Boudou-Rouquette P, Bertucci F, Balleyguier C, Lebrun-Ly V, Ray-Coquard I, Kalbacher E, Bardet A, Bompas E, Collard O, Isambert N, Guillemet C, Rios M, Archambaud B, Duffaud F; French Sarcoma Group. Pautier P, et al. Among authors: balleyguier c. Lancet Oncol. 2022 Aug;23(8):1044-1054. doi: 10.1016/S1470-2045(22)00380-1. Epub 2022 Jul 11. Lancet Oncol. 2022. PMID: 35835135 Clinical Trial.
Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy : correlation of radiologic findings with surgicopathologic results.
Vincens E, Balleyguier C, Rey A, Uzan C, Zareski E, Gouy S, Pautier P, Duvillard P, Haie-Meder C, Morice P. Vincens E, et al. Among authors: balleyguier c. Cancer. 2008 Oct 15;113(8):2158-65. doi: 10.1002/cncr.23817. Cancer. 2008. PMID: 18780318 Free article.
[New drugs and targeted therapeutic agents in ovarian cancer].
de La Motte Rouge T, Petrella MC, Michels J, Even C, Balleyguier C, Duclos J, Mazeron R, Morice P, Pautier P, Lhommé C. de La Motte Rouge T, et al. Among authors: balleyguier c. Bull Cancer. 2009 Dec;96(12):1215-24. doi: 10.1684/bdc.2009.0988. Bull Cancer. 2009. PMID: 19919916 Free article. Review. French.
[First line chemotherapy of advanced epithelial ovarian cancer].
Lhommé C, Even C, Morice P, Balleyguier C, Petrella M, Gouy S, Uzan C, Duvillard P, Pautier P. Lhommé C, et al. Among authors: balleyguier c. Bull Cancer. 2009 Dec;96(12):1207-13. doi: 10.1684/bdc.2009.0987. Bull Cancer. 2009. PMID: 19948450 Free article. French.
[Ovarian yolk sac tumour: general review].
Even C, Lhommé C, Duvillard P, Morice P, Balleyguier C, Pautier P, Troalen F, de La Motte Rouge T. Even C, et al. Among authors: balleyguier c. Bull Cancer. 2011 Aug;98(8):963-75. doi: 10.1684/bdc.2011.1387. Bull Cancer. 2011. PMID: 21708513 Free article. Review. French.
Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.
Even C, Pautier P, Duvillard P, Floquet A, Kerbrat P, Troalen F, Rey A, Balleyguier C, Tazi Y, Leary A, Augereau P, Morice P, Droz JP, Fizazi K, Lhommé C. Even C, et al. Among authors: balleyguier c. Eur J Cancer. 2014 Aug;50(12):2082-9. doi: 10.1016/j.ejca.2014.05.002. Epub 2014 Jun 5. Eur J Cancer. 2014. PMID: 24910417
193 results